Your English writing platform
Discover LudwigExact(7)
Founders who register for Disrupt provide information on their company – category, stage, location, funding status.
Founders provide info about their startup — such as category, stage, location and funding status — while investor profiles include things like investment categories, preferred funding stage and geographic preferences.
When a founder signs up for Disrupt, as an attendee or an exhibitor, we also ask them to sign up for CrunchMatch and provide information on their startup — category, stage, location, funding status, etc.
If you're an investor or a founder coming to Disrupt SF, you'll be invited to sign up for CrunchMatch (through our partner Brella) and build out your profile — for founders it's category, stage, location, funding status, etc. and for investors it's investment categories, preferred funding stage, geographic preferences and the like.
*Variables removed from the model (P > 0.05): Gleason category, stage (pT) category, seminal vesicle involvement.
As expected, tumours arising in the larynx, those with T1-2 category, stage I-II and patients without lymph node involvement, had a better prognosis (p < 0.05).
Similar(53)
This analysis also showed that the sixth edition T category staging did not significantly influence prognosis (p = 0.4376).
The prognostic value of the seventh edition T category staging was confirmed by Cox proportional hazards regression analysis (p = 0.0014, Table 4).
The remaining patient cohort showed the expected prognosticators concerning age, gender, T-category, stage and histology (data not shown).
Concerning the clinical characteristics, neither of the measures of tumour radiosensitivity was correlated with T- and N-category, stage, tumour size, sex and age.
Of these two categories, stage IIIB is also considered inoperable disease.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com